Purchase Order N0018319P0811
Award Date 9/27/19
Potential Completion Date 9/26/24
Potential Value $66K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Cerus Corporation was awarded a firm fixed price purchase order by the Defense Health Agency for $66,388 to provide service maintenance for two Cerus INTERCEPT Illuminators over a five year period from September 2019 through September 2024. The INTERCEPT Illuminators are pathogen reduction systems owned by the Naval Medical Center San Diego that use ultraviolet light and chemicals to inactivate pathogens in blood platelets. Cerus Corporation will provide all necessary services, materials, and...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for the maintenance of INTERCEPT Blood System illuminators, which are used to inactivate pathogens in blood components. The contract has a ceiling value of $45,898.00 and a period of performance from September 27, 2024, to September 26, 2027. Cerus Corporation is the prime contractor, and there are no...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for a Preventative Maintenance Agreement for the INTERCEPT Blood System Illuminators, with a period of performance from July 15, 2025, to July 14, 2026, and a ceiling value of $15,372.00. The contract does not have a set-aside designation. Cerus Corporation is the...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company, for $45,898.00. The contract is for service and maintenance of the Cerus Illuminator, a device used in the lab at the Naval Medical Center San Diego. The period of performance runs from October 1, 2024 to September 30, 2027. This contract does not have a set-aside designation. Cerus Corporation is a for-profit manufacturer specializing in blood safety...
- The Defense Health Agency awarded a Firm Fixed Price, $186,048.00 purchase order contract to Cerus Corporation, a biomedical products manufacturer, for the drop shipment of medical supplies. The contract is sole source and not set aside. The supplies include the INTERCEPT Blood System technology, which uses riboflavin and UV light to inactivate pathogens in blood platelets and plasma. Cerus has received over 20 federal contract awards since 2002 from agencies such as the Department of Defense,...
- This is a sole-source, firm-fixed-price federal contract awarded by the Defense Health Agency (DHA) to Cerus Corporation for annual onsite preventive maintenance of two Intercept Pathogen Reduction Systems located at the United States Naval Hospital Okinawa in Japan. The contract, valued at $68,398.00, covers a one-year base period plus two option years, running from February 9, 2025, to February 8, 2028. Cerus Corporation is the sole provider of these services due to the proprietary and...
- The Defense Health Agency (DOD) awarded a $367,504.80 firm fixed price purchase order to Cerus Corporation to provide INTERCEPT Platelet Processing and Service Maintenance for the Walter Reed National Military Center in Bethesda, Maryland from January 13, 2022 through January 31, 2027. Cerus Corporation will supply its INTERCEPT Blood System for platelets, which utilizes ultraviolet light and riboflavin to inactivate pathogens in platelet components during the collection and storage process,...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract, valued at $14,924.64, is for the provision of INTERCEPT Blood System equipment, illuminator maintenance services, and specialized pathogen reduction technology products. The contract has a performance period ending on June 7, 2025. Cerus...
- The Defense Health Agency awarded a $82,830.00 firm fixed price purchase order to Cerus Corporation, a biomedical products company, for preventative maintenance on two Nucleic Acid Processor INT 100-60 systems being utilized at the Armed Services Blood Bank Center in Okinawa, Japan. The contract has a base year plus four option years, with a completion date of February 8, 2025. Cerus Corporation was selected on a sole source basis as the original equipment manufacturer with proprietary rights to...
- This federal contract award is for the purchase of an ILLUMINATOR 60HZ - EQUIPMENT by the Department of the Navy Bureau of Medicine and Surgery. The $116,240.00 firm fixed price contract was awarded to Cerus Corporation, a for-profit manufacturer of biomedical products related to blood safety and pathogen reduction. This award is not associated with a set-aside program. Cerus has received over 20 prior federal contracts from agencies such as the Defense Health Agency, Department of Defense,...